CardioKinetix (Menlo Park, California), a firm that's in the process of developing a catheter-based treatment for heart failure, reported results of a pooled analysis study of the first-of-its-kind catheter-based Parachute Ventricular Partitioning device. Twelve-month clinical results from 111 consecutive U.S. and European patients with ischemic heart failure were presented last week, at the American College of Cardiology (Washington) annual meeting, by Philip Adamson, MD, medical director at the Heart Failure Institute at Oklahoma Heart Hospital. Read More
